Health products quarantined from two India sites

 At Health Canada's request, Canadian importers have agreed to quarantine health products from the following two India-based sites due to data integrity concerns:

  • Dr. Reddy's Laboratories in Srikakulam, India
  • IPCA Laboratories in Pithampur, India

These lists are based on the most recent information received by Health Canada as of December 23, 2014. The lists will continue to be updated as new information becomes available.

Medically Necessary Products

To date no products manufactured at these sites for the Canadian market have been determined to be medically necessary. Products will continue to be assessed for medical necessity and the list will be updated should new information become available.

Non Medically Necessary Products

Products manufactured with active pharmaceutical ingredients (API) from Dr. Reddy's Laboratories
Company Name Product Name
Mylan Pharmaceuticals Mylan - Domperidone
Pharmascience Desloratadine Allergy Control
PMS-Domperidone
PMS-Valsartan
Sandoz Canada Inc Sandoz Capecitabine
Sandoz Naratriptan
Teva Canada Teva - Naratriptan
 
Finished products from IPCA Laboratories
Company Name Product Name
International Pharmaceutical Generics (IPG) Quetiapine
Jamp Pharma JAMP-ACET-TRAMADOL
Marcan Pharmaceuticals MAR-Quetiapine
MAR-Tramadol/Acet
Mint Pharmaceuticals Mint-Ondansetron
Mint-Tramadol/Acet
Pharmapar PRIVA-Tramadol/Acet
Ranbaxy Pharmaceuticals RAN-Tramadol/Acet
Riva Laboratories RIVA-Tramadol/Acet
Report a problem or mistake on this page
Please select all that apply:

Privacy statement

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: